Integration of Stepped Care for Perinatal Mood and Anxiety Disorders Among Women Attending MCH Clinics
Recruiting now · Not applicable
Conditions studied: Depression, Anxiety, Antenatal Depression, Postnatal Depression
In brief
Perinatal mood and anxiety disorders (PMAD), defined as depression and anxiety during pregnancy or up to 1 year postpartum, account for substantial morbidity and mortality among birthing people globally especially in low- and middle-income countries. Several evidence-based interventions are recommended for identification and management of PMAD by non-specialist providers in resource-limited settings. This cluster-randomized trial seeks to evaluate the effect of a stepped-care intervention for screening and treatment of PMAD among perinatal women, on clinical and implementation outcomes.
Key facts
- Study ID
- NCT06456307
- Run by
- Kenyatta National Hospital
- People needed
- 2970
- Starts
- 2025-02-17
- Expected to finish
- 2028-03-01
- Last updated by the study team
- 2025-12-10
Who can join
Age: 14 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Pregnant and ≥28 weeks gestation
- Attending ANC care at the facility
- ≥14 years old
- Screen positive for PMAD symptoms (PHQ-2≥3 and/or GAD-2≥3)
- Willing to return to the MCH and PMTCT clinic for study visits
You may not qualify if…
- Less than 28 weeks gestation
- Any woman at high risk of self-harm based on a study self-harm assessment protocol,
- Has cognitive impairments or psychotic symptoms
Where it is running
- Kenyatta National Hospital — Nairobi, Kenya (enrolling)
- HomaBay, Siaya and Kisumu — Western Kenya, Kenya (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.